S. Cohen

发表

Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis.

S. Forman, D. Snyder, V. Pullarkat, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal

G. Sauvageau, P. Zandstra, E. Csaszar, 2014, Science.

Guidelines for Cord Blood Unit Selection.

J. Wagner, E. Shpall, A. Scaradavou, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Real-world outcomes of autologous and allogeneic hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma in the era of novel therapies: a Canadian perspective.

G. Sauvageau, I. Ahmad, H. Alaoui, 2021, Transplantation and cellular therapy.

Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence of GVHD prophylaxis

G. Sauvageau, C. Perreault, K. Rezvani, 2019, British journal of haematology.

Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering.

R. Ciccocioppo, Athena L. Russell, S. Prockop, 2023, Cytotherapy.

Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single‐center study in Québec, Canada

K. Marr, M. Laverdière, C. Lavallée, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Allogeneic and Autologous Stem Cell Transplantation for Acute Leukemia and Myelodysplasia in the Adult

S. Forman, Sandra Cohen, S. Cohen, 2004 .

Biopsy Proven Late-Onset Sinusoidal Obstruction Syndrome Successfully Treated With Defibrotide

I. Ahmad, S. Lachance, H. Jamali, 2015 .

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial.

N. Schmitz, H. Döhner, M. Hallek, 2010, Blood.

Allogeneic Stem Cell Transplantation Can Overcome the Adverse Prognostic Impact of TP53 Mutation In Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3x Trial

N. Schmitz, H. Döhner, M. Hallek, 2010 .

results of the German CLL Study Group CLL3X trial poor-risk chronic lymphocytic leukemia: long-term clinical and MRD Allogeneic stem cell transplantation provides durable disease control in

N. Schmitz, M. Hallek, S. Stilgenbauer, 2011 .

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia : long-term clinical and MRD results of the German CLL Study Group CLL 3 X trial

N. Schmitz, H. Döhner, M. Hallek, 2010 .

Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome

G. Sauvageau, I. Ahmad, D. Roy, 2022, Current oncology.

Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment.

R. Ciccocioppo, M. Stanojevic, Athena L. Russell, 2022, Cytotherapy.

High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation.

D. Kent, V. Martel-Laferrière, D. Snydman, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality.

G. Sauvageau, L. Busque, S. Lachance, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease.

G. Sauvageau, I. Ahmad, S. Lachance, 2019, Leukemia research.

Defining the role of sirolimus in the management of graft-versus-host disease: from prophylaxis to treatment.

S. Lachance, T. Kiss, Sandra Cohen, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.

A. Nademanee, A. Krishnan, G. Somlo, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

International society for cell & gene therapy stem cell engineering committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.

Athena L. Russell, M. Pavel-Dinu, S. Prockop, 2023, Cytotherapy.

Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.

Athena L. Russell, S. Prockop, J. Boelens, 2021, Cytotherapy.

Haploidentical Stem Cell Transplantation: High Doses of Alloreactive-T Cell Depleted Donor Lymphocytes Administered Post-Transplant Decrease Infections and Improve Survival without Causing Severe Gvhd.

G. Sauvageau, L. Busque, D. Fish, 2009 .

Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study

G. Sauvageau, S. Landais, D. Ogez, 2021, Bone Marrow Transplantation.

Small molecule regulation of normal and leukemic stem cells

G. Sauvageau, I. Fares, Sandra Cohen, 2015, Current opinion in hematology.

High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.

G. Sauvageau, L. Busque, S. Lachance, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Reduce Transplant Related Mortality and Improve Overall Survival in Haploidentical HSCT for Patients with AML and ALL, Using an Immunosuppressant-Free Transplant Regimen

S. Lachance, S. Mielke, J. Velthuis, 2015 .

Reduction in Incidence of Severe Infections by Transplantation of High Doses of Haploidentical T Cells Selectively Depleted of Alloreactive Units

G. Sauvageau, C. Perreault, K. Rezvani, 2011 .

Bortezomib maintenance after allogeneic transplantation in newly diagnosed myeloma patients results in decreased incidence and severity of chronic GVHD.

G. Sauvageau, I. Ahmad, S. Lachance, 2022, Transplantation and cellular therapy.

Newly diagnosed multiple myeloma patients treated with tandem auto‐allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only

G. Sauvageau, S. Landais, I. Ahmad, 2020, Clinical transplantation.

Tandem autologous-allogeneic nonmyeloablative sibling transplantation in relapsed follicular lymphoma leads to impressive progression-free survival with minimal toxicity.

G. Sauvageau, L. Busque, I. Ahmad, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.

G. Sauvageau, L. Busque, I. Ahmad, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease.

D. Allan, C. Perreault, C. Scotto, 2010, Blood.

Chronic myeloid leukemia with an e13a3 BCR‐ABL fusion: Benign course responsive to imatinib with an RT‐PCR advisory

M. Slovak, D. Snyder, R. McMahon, 2004, American journal of hematology.

Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.

J. Connors, K. Savage, T. Panzarella, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.

J. Connors, K. Savage, T. Panzarella, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Implementing a Bendamustine-based Conditioning Regimen on outcomes of Autologous Stem Cell Transplant in Lymphoma while Novel Cellular Therapies Emerge.

G. Sauvageau, I. Ahmad, I. Fleury, 2022, Transplantation and cellular therapy.

Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Lymphoma Patients.

G. Sauvageau, I. Ahmad, S. Lachance, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma.

G. Sauvageau, L. Busque, I. Ahmad, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities.

G. Sauvageau, W. van't Hof, Marie-Christine Meunier, 2022, Transplantation and cellular therapy.

Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.

G. Sauvageau, S. Landais, S. Lemieux, 2019, The Lancet. Haematology.

UM171-expanded cord blood transplants support robust T cell reconstitution with low rates of severe infections.

G. Sauvageau, S. Lemieux, C. Perreault, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Single UM171‐expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors

G. Sauvageau, L. Busque, I. Ahmad, 2020, European journal of haematology.

Blood stem cell products: toward sustainable benchmarks for clinical translation.

Sandra Cohen, Elizabeth Csaszar, Peter W. Zandstra, 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.

Atypical Chronic Lymphocytic Leukemia with CD200 Expression Shares Similar Outcomes to Classical Chronic Lymphocytic Leukemia

I. Fleury, R. LeBlanc, L. Mollica, 2016 .

Single UM171 Expanded Cord Blood Permits Transplantation of Better HLA Matched Cords with Excellent Gvhd Relapse Free Survival

G. Sauvageau, S. Lemieux, P. Zandstra, 2018, Blood.

Expanding the indications for ibrutinib : complete remission obtained by induction with ibrutinib followed by consolidative aHSCT in refractory primary CNS lymphoma

G. Sauvageau, L. Busque, I. Ahmad, 2020 .

UM171 Is a Novel and Potent Agonist Of Human Hematopoietic Stem Cell Renewal

G. Sauvageau, P. Zandstra, E. Csaszar, 2013 .

Tandem autologous-allogeneic nonmyeloablative sibling transplantation in relapsed follicular lymphoma leads to impressive progression-free survival with minimal toxicity.

G. Sauvageau, L. Busque, I. Ahmad, 2012, Biology of Blood and Marrow Transplantation.

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial.

N. Schmitz, H. Döhner, M. Hallek, 2010, Blood.

Donor lymphocytes depleted of alloreactive T-cells (ATIR101) improve overall survival and reduce transplant related mortality in a T-cell depleted haploidentical HSCT: Results from a Phase 2 trial in patients with AML and ALL

M. Ruediger, S. Lachance, S. Mielke, 2016 .

Cerebral adenovirus endotheliitis presenting as posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation

I. Ahmad, S. Lachance, J. Delisle, 2017, Bone Marrow Transplantation.

Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation

G. Sauvageau, L. Busque, I. Ahmad, 2016, Bone Marrow Transplantation.

Nocardiosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Matched Case-Control Study of Risk Factors, Clinical Features and Outcomes

G. Sauvageau, S. Lachance, M. Chagnon, 2013 .

Blood stem cell products: toward sustainable benchmarks for clinical translation.

P. Zandstra, E. Csaszar, S. Cohen, 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.

Single UM171 Expanded Cord Blood Transplant is Feasible, Safe, and Permits Transplantation of Better HLA Matched Cords with Very Low Transplant Related Mortality

G. Sauvageau, S. Lemieux, P. Zandstra, 2018 .

Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.

G. Sauvageau, L. Busque, I. Ahmad, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.